Big Pharma Biotech Investment - Mitarbeiter (anonym) bei Merck: Mitarbeiterbewertung

2.0
25. Aug. 2010
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

An increased drive to invest in biotech by the big pharmas has lead this career in a positive direction. Good team environment.

Kontras

Lack of drive within management to promote and advance employees throughout two large mergers though there were plenty of new hires. Lack of opportunity for training/conferences/education.

Mehr Bewertungen zu Merck entdecken

5.0
15. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Manager is good. Communication is good.

Kontras

Salary is not very competitive

4.0
2. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Kontras

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle